Conmed Corp’s recently made public that its Executive Vice President & CFO Garner Todd W unloaded Company’s shares for reported $31365.0 on Aug 07 ’25. In the deal valued at $52.45 per share,598 shares were sold. As a result of this transaction, Garner Todd W now holds 0 shares worth roughly $0.0.
Then, Garner Todd W bought 598 shares, generating $31,365 in total proceeds.
Before that, Farkas Charles sold 4,000 shares. Conmed Corp shares valued at $227,768 were divested by the Director at a price of $56.94 per share. As a result of the transaction, Farkas Charles now holds 16,346 shares, worth roughly $0.88 million.
Needham downgraded its Conmed Corp [CNMD] rating to a Hold from a a Buy in a research note published recently. A number of analysts have revised their coverage, including Stifel’s analysts, who decreased its forecast for the stock in late April from “a Buy” to “a Hold”. JP Morgan also remained covering CNMD and has decreased its forecast on February 06, 2025 with a “Neutral” recommendation from previously “an Overweight” rating. Needham maintained its rating on February 01, 2024. It rated CNMD as “a Buy”.
Price Performance Review of CNMD
On Tuesday, Conmed Corp [NYSE:CNMD] saw its stock jump 2.92% to $54.01. Over the last five days, the stock has gained 0.95%. Conmed Corp shares have fallen nearly -20.36% since the year began. Nevertheless, the stocks have fallen -21.08% over the past one year. While a 52-week high of $78.19 was reached on 02/05/25, a 52-week low of $46.00 was recorded on 04/21/25.
Levels Of Support And Resistance For CNMD Stock
The 24-hour chart illustrates a support level at 53.14, which if violated will result in even more drops to 52.26. On the upside, there is a resistance level at 54.56. A further resistance level may holdings at 55.10.
How much short interest is there in Conmed Corp?
A steep rise in short interest was recorded in Conmed Corp stocks on 2025-07-31, dropping by -0.18 million shares to a total of 2.1 million shares. Yahoo Finance data shows the prior-month short interest on 2025-06-30 was 2.27 million shares. There was a decline of -8.44%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on May 22, 2023 when CL King began covering the stock and recommended ‘”a Buy”‘ rating along with a $140 price target.
